Registry Protocol- Melphalan Percutaneous Hepatic Perfusion for the Treatment of Unresectable Hepatic Malignancy

Clinical trial NCT03266042 · UNKNOWN

Trial details

NCT number: NCT03266042
Sponsor: Delcath Systems Inc.
Status: UNKNOWN
Study type: OBSERVATIONAL

Hepatic Malignant Neoplasm Primary Non-Resectable

Start date: 2016-01-14
Primary completion: 2020-01-01
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.